Reuters Health Report

On your mobile? Click here to view this email in text. If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good evening Srini, WED 03 Dec 2008  today's headlines Obese children risk thyroid damage Brand-name drugs no better than generics: study Carrot juice botulism outbreak prompts FDA action Saudi milk contamination finding rejected by Nestle Aggressive drug marketing may endanger people Contaminant confirmed in tainted heparin Multiple sclerosis seen associated with headache Exercise may speed weight loss after gastric bypass Binge-drinking may raise stroke risk Exercise helps overweight kids with anger   more details Obese children risk thyroid damage December 03, 2008 10:13 AM ET WASHINGTON (Reuters) - Obese children may be damaging their thyroids, creating a vicious cycle of metabolism and overweight, Italian researchers reported on Wednesday. Full Article Brand-name drugs no better than generics: study December 03, 2008 01:56 PM ET WASHINGTON (Reuters) - There is no evidence that brand-name drugs given to treat heart and other cardiovascular conditions work any better than their cheaper generic counterparts, U.S. researchers said on Tuesday. Full Article Carrot juice botulism outbreak prompts FDA action December 03, 2008 12:09 PM ET NEW YORK (Reuters Health) - In September 2006, three people living in Georgia developed food-borne botulism that was eventually traced to commercial carrot juice from a single bottle. Soon thereafter an additional case in Florida and two in Ontario, Canada surfaced. Full Article Saudi milk contamination finding rejected by Nestle December 03, 2008 12:00 PM ET RIYADH (Reuters) - Saudi Arabia said on Wednesday that harmful concentrations of melamine had been found in milk powder made by a Nestle plant in China but the world's largest food group rejected the report. Full Article Aggressive drug marketing may endanger people December 03, 2008 06:00 AM ET WASHINGTON (Reuters) - Quicker drug approvals and sophisticated marketing campaigns may be putting more patients at risk of dangerous side-effects but the same techniques might be put to use to protect them, a researcher argued on Tuesday. Full Article Contaminant confirmed in tainted heparin December 03, 2008 05:30 PM ET BOSTON (Reuters) - The contaminant linked to dozens of deaths and hundreds of illnesses from tainted batches of the blood thinner heparin manufactured in China was chemically related to a dietary supplement used to treat joint pain, researchers confirmed on Wednesday. Full Article Multiple sclerosis seen associated with headache December 03, 2008 03:31 PM ET NEW YORK (Reuters Health) - Patients with multiple sclerosis are more apt to suffer from headaches than the general population, results of a study hint. Full Article Exercise may speed weight loss after gastric bypass December 03, 2008 01:22 PM ET NEW YORK (Reuters Health) - People who've undergone surgery to manage their obesity may lose more weight if they start exercising, a new study suggests. Full Article Binge-drinking may raise stroke risk December 03, 2008 01:20 PM ET NEW YORK (Reuters Health) - People who occasionally binge-drink may have a heightened long-term risk of suffering a stroke, even if they do not regularly drink heavily, a new study suggests. Full Article Exercise helps overweight kids with anger December 03, 2008 03:31 PM ET NEW YORK (Reuters Health) - Sedentary overweight children who start exercising after school become more fit -- and may also be less likely to slam doors, hit other children, and express their anger in other aggressive ways, researchers report. Full Article     . REUTERS www.reuters.com Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details Subscribe to other Reuters newsletters Unsubscribe from this newsletter. Send this mailing to a friend or colleague Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers